|
|
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model.
Azam Bolhassani
,
Elham Gholami
,
Farnaz Zahedifard
,
Neda Moradin
,
Parto Parsi
,
et al.
Journal articles
istex
pasteur-00786634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.
Elham Mohit
,
Azam Bolhassani
,
Farnaz Zahedifard
,
Negar Seyed
,
Ali Eslamifar
,
et al.
Journal articles
pasteur-00789216v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
Negar Seyed
,
Farnaz Zahedifard
,
Shima Safaiyan
,
Elham Gholami
,
Fatemeh Doustdari
,
et al.
Journal articles
pasteur-00787351v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth.
Mahdi Behdani
,
Sirous Zeinali
,
Morteza Karimipour
,
Hossein Khanahmad
,
Steve Schoonooghe
,
et al.
Journal articles
pasteur-00821222v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies.
Azam Bolhassani
,
Taheri Tahereh
,
Yasaman Taslimi
,
Soheila Zamanilui
,
Farnaz Zahedifard
,
et al.
Journal articles
istex
pasteur-00786977v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|